Pesticides in children

J R Reigart1, J R Roberts

  • 1Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina, USA.

Insights

Children face unique pesticide exposures and health risks, including cancer and neurodevelopmental issues. Pediatricians should advise families on avoiding these environmental toxins.

Area of Science:

  • Environmental Health
  • Pediatric Toxicology
  • Public Health Policy

Background:

  • Children exhibit distinct physiological and exposure profiles compared to adults regarding environmental toxins.
  • Pesticide exposure encompasses a broad spectrum, including insecticides, herbicides, fungicides, and rodenticides.
  • Understanding these differences is crucial for assessing pediatric health risks.

Purpose of the Study:

  • To review the acute and chronic toxicity of pesticides in children.
  • To examine significant chronic health effects such as carcinogenesis, endocrine disruption, and neurodevelopmental impacts.
  • To discuss current regulations and provide recommendations for pediatricians.

Main Methods:

  • Literature review of existing studies on pediatric pesticide exposure and toxicity.
  • Analysis of toxicological data focusing on chronic health outcomes.
  • Examination of legislative and regulatory frameworks governing pesticide use.

Main Results:

  • Children's unique metabolism and behaviors lead to differential exposure levels and toxicological responses.
  • Key chronic risks identified include increased susceptibility to cancer, endocrine disruption, and adverse neurodevelopmental effects.
  • Current laws and regulations present challenges and opportunities for mitigating pediatric exposure.

Conclusions:

  • Pesticide exposure poses significant health risks to children, necessitating targeted interventions.
  • Pediatricians play a vital role in educating families and advocating for protective measures.
  • Further research and policy development are needed to enhance child safety from pesticides.

Related Concept Videos

Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Microbial Bioremediation of Pesticides01:28

Microbial Bioremediation of Pesticides

Pesticides often feature structurally complex chemical architectures, incorporating halogen groups and multiple aromatic rings. These characteristics confer high chemical stability, rendering many pesticides resistant to natural degradation processes. This resistance poses significant environmental concerns, as persistent pesticide residues can accumulate in ecosystems and affect non-target organisms.Despite the inherent stability of many pesticides, certain microorganisms possess the metabolic...